-
Nov 21, 2021
-
Nov 17, 2021
-
Nov 17, 2021
-
Nov 17, 2021
-
Nov 17, 2021
-
Biotium has announced the release of EvaRuby™ Dye for qPCR and HRM®.
Nov 14, 2021
-
Nov 14, 2021
-
Thermo Fisher Scientific has announced a series of co-marketing agreements, in addition to a new chromatography system and acquisition, to support scientists in driving their proteomics research forwards.
Nov 14, 2021
-
Inflammatix was awarded a $1.7 million grant from the National Institutes of Health (NIH) to support its development of a rapid diagnostic to identify immune subtypes (endotypes) of sepsis. Sepsis is a challenging disease with no available treatments, and the new test may enable endotype-specific therapies and/or the repurposing of available drugs to better treat sepsis.
Nov 10, 2021
-
Nov 14, 2021
-
Oct 24, 2021
-
BioPharma Dynamics has announced the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester
Oct 25, 2021
-
Ubiquigent has today announced the extension and expansion of its long-term collaboration with Bristol Myers Squibb.
Oct 25, 2021
-
Oct 30, 2021
-
Oct 30, 2021
-
VERICHEM offers an extensive line of combined Total Protein/Albumin clinical reference materials specifically designed and manufactured for the calibration and calibration verification of Albumin and Total Protein assays on a wide number of clinical testing systems, including those from Abbott Diagnostics, Beckman Coulter, Roche Diagnostics, Siemens Healthineers.
Nov 1, 2021
-
Stratix Labs has unveiled Instant Inoculator™ QC microorganisms, a novel, ready-to-use product that delivers reference microorganisms to solid media with a simple one-step method.
Nov 1, 2021
-
The first multisite oncology trial undertaken by the independent sector in the UK has started treating its first patient at the Rutherford Cancer Centre North East.
Nov 1, 2021
-
230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development
Nov 4, 2021
-
The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs
Nov 2, 2021